arginine has been researched along with nateglinide in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Desai, M; Huang, WX; Joshi, Y; Tang, Q; Vivilecchia, RV; Yang, R | 1 |
Gao, HW; Hong, TP; Lin, YJ; Wang, HN; Xie, C | 1 |
1 review(s) available for arginine and nateglinide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for arginine and nateglinide
Article | Year |
---|---|
Beneficial metabolic effects of nateglinide versus acarbose in patients with newly-diagnosed type 2 diabetes.
Topics: Acarbose; Arginine; Blood Glucose; Cross-Over Studies; Cyclohexanes; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Insulin; Lipids; Male; Middle Aged; Nateglinide; Phenylalanine; Prospective Studies | 2007 |
1 other study(ies) available for arginine and nateglinide
Article | Year |
---|---|
Elimination of metformin-croscarmellose sodium interaction by competition.
Topics: Arginine; Binding, Competitive; Carboxymethylcellulose Sodium; Cyclohexanes; Drug Combinations; Excipients; Hypoglycemic Agents; Metformin; Models, Chemical; Nateglinide; Phenylalanine; Tablets; Technology, Pharmaceutical | 2006 |